HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Virtual Screening Inhibitors of Ubiquitin-specific Protease 7 Combining Pharmacophore Modeling and Molecular Docking.

Abstract
Ubiquitin-specific protease 7 (USP7) is one of the most extensively studied deubiquitinases. USP7 exhibits a high expression signature in various malignant tumors, suggesting that it is a marker of tumor prognosis and a potential drug target for anti-tumor therapy. In this study, virtual screening based on pharmacophore model and biological evaluation have been applied for the discovery of novel USP7 inhibitors targeting the catalytic active site. The TS-4 was screened from 215,480 small molecules and was found to have USP7 inhibitory activity. Preliminary in vitro studies disclosed its antiproliferative activity on human colon cancer cell lines (HCT-116 and RKO), compared with normal colon cell line (CCD841CoN). Molecular dynamics (MD) simulation revealed the combine mechanism between USP7 with the TS-4. The TS-4 formed stable interactions with Asp295, Phe409 and Tyr514, which were critical to enhance its biological activity. This compound will serve as a promising hit compound for facilitating the further design of novel USP7 inhibitors.
AuthorsSiyu Zhang, Yifan Wang, Lu Liu, Guangjian Zhao, Yujie Sun, Juan Wang, Fang Liu, Peng Wang, Ximing Xu
JournalMolecular informatics (Mol Inform) Vol. 41 Issue 7 Pg. e2100273 (07 2022) ISSN: 1868-1751 [Electronic] Germany
PMID35037416 (Publication Type: Journal Article)
Copyright© 2022 Wiley-VCH GmbH.
Chemical References
  • USP7 protein, human
  • Ubiquitin-Specific Peptidase 7
Topics
  • Humans
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Neoplasms (drug therapy)
  • Ubiquitin-Specific Peptidase 7 (antagonists & inhibitors, chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: